# Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence

> **NCT00003645** · PHASE3 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 64 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Flutamide
- **DRUG:** Leuprolide Acetate

## Key facts

- **NCT ID:** NCT00003645
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1999-06-14
- **Primary completion:** 2017-03-20
- **Final completion:** 2017-03-20
- **Target enrollment:** 64 (ACTUAL)
- **Why stopped:** Per PI request
- **Last updated:** 2020-04-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003645, "Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*